Update on the therapy of adult-onset Still’s disease with a focus on IL-1-inhibition: a systematic review
Introduction: The past decade has seen increasingly rapid advances in understanding the pathogenic nature of adult-onset Still’s disease (AOSD) and its shared symptoms with the systemic juvenile idiopathic arthritis (sJIA). Interleukin-1 (IL-1) blocking agents are key elements in the treatment. In t...
Guardado en:
Autores principales: | Claudia Kedor, Stylianos Tomaras, Daniel Baeumer, Eugen Feist |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dee9f4fe5cf94ac3bd725ba8d1336885 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adult-onset Still's disease: current challenges and future prospects
por: Siddiqui M, et al.
Publicado: (2016) -
Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz J, et al.
Publicado: (2015) -
Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009) -
Update on the diagnosis and management of Behçet’s disease
por: Rokutanda R, et al.
Publicado: (2014) -
New developments in the treatment of osteoarthritis – focus on biologic agents
por: Torrero JI, et al.
Publicado: (2015)